Zai Lab Announces Upcoming Presentations in September Investor Conferences

Rhea-AI Summary

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) announced its participation in two upcoming virtual investor conferences in September 2021. The Jefferies Asia Forum will be held on September 8 at 7:00 p.m. HKT, followed by a Fireside Chat at Citi’s 16th Annual BioPharma Virtual Conference on September 10 at 11:35 a.m. EDT. Live webcasts will be accessible under the "Events & Presentations" section of Zai Lab's website, with an archive available for 90 days post-event. Zai Lab focuses on innovative therapies in oncology, autoimmune disorders, and infectious diseases.

SHANGHAI and SAN FRANCISCO, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (“Zai Lab”) (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today announced that management from Zai Lab will be presenting at the following upcoming virtual investor conferences in September:

Jefferies Asia Forum
Presentation: Wednesday, September 8, 2021 at 7:00 p.m. HKT

Citi’s 16th Annual BioPharma Virtual Conference
Fireside Chat: Friday, September 10, 2021 at 11:35 a.m. EDT

Live webcasts of the conferences will be available under “Events & Presentations” in the “Investor Relations” section of Zai Lab’s website. An archived replay will be available for 90 days following the event.

About Zai Lab

Zai Lab (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company focused on developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders and infectious disease. To that end, our experienced team has secured partnerships with leading global biopharmaceutical companies in order to generate a broad pipeline of innovative marketed products and product candidates. We have also built an in-house team with strong product discovery and translational research capabilities and are establishing a pipeline of proprietary product candidates with global rights. Our vision is to become a leading global biopharmaceutical company, discovering, developing, manufacturing and commercializing our portfolio in order to impact human health worldwide.

For additional information about the company, please visit www.zailaboratory.com or follow us at www.twitter.com/ZaiLab_Global.

For more information, please contact:

ZAI LAB CONTACTS:

Zai Lab
Billy Cho, CFO
+86 137 6151 2501
billy.cho@zailaboratory.com

Media: Ryo Imai / Robert Flamm, Ph.D.
Burns McClellan, on behalf of Zai Lab
212-213-0006 ext. 315 / 364
rimai@burnsmc.com / rflamm@burnsmc.com

Investors: Pete Rahmer / Mike Zanoni
Endurance Advisors, on behalf of Zai Lab
415-515-9763 / 610-442-8570
prahmer@enduranceadvisors.com / mzanoni@enduranceadvisors.com

Zai Lab Limited

Source: Zai Lab Limited

FAQ

When is Zai Lab presenting at the Jefferies Asia Forum?

Zai Lab will present at the Jefferies Asia Forum on September 8, 2021, at 7:00 p.m. HKT.

What date is Zai Lab participating in Citi’s BioPharma Virtual Conference?

Zai Lab will participate in Citi’s 16th Annual BioPharma Virtual Conference on September 10, 2021, at 11:35 a.m. EDT.

Where can I watch Zai Lab's conference presentations?

You can watch Zai Lab's conference presentations live by visiting the "Events & Presentations" section on their website.

How long will the recordings of Zai Lab's conferences be available?

The recordings of Zai Lab's conferences will be available for 90 days following the event.

What areas does Zai Lab focus on in biopharmaceuticals?

Zai Lab focuses on developing therapies in oncology, autoimmune disorders, and infectious diseases.